A COVID-19 vaccine made in Taiwan by Medigen Vaccine Biologics Corp. has received emergency use authorization (EUA) in Paraguay after the unblinding of a Phase 3 clinical trial conducted in the South American country, the company said in a statement Monday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Typhoon Danas makes landfall in Taiwan's Chiayi County
07/07/2025 01:07 AM - Society
Northern Taiwan cities declare business as usual Monday despite storm
07/06/2025 09:26 PM - Society
Typhoon Danas outer band touches southern Taiwan, rain intensifies
07/06/2025 09:26 PM - Society
High speed rail to only run all-stop, non-reserved trains Monday
07/06/2025 09:17 PM - Society
6 cities/counties to close schools, offices Monday due to typhoon
07/06/2025 06:13 PM